GCTK:OTC, GlucoTrack, Inc.
GCTK stock overview
GlucoTrack, Inc. (GCTK:OTC) closed at $0.217 on November 13, 2026,
down 9.67% on the day.
It is trading at its 52-week low of $0.217.
GlucoTrack, Inc. is part of the Health Care sector.
Key figures
- Price
- $0.217
- Day change
- -9.67%
- Volume
- 7,384
- Average volume
- 1,871,572
- Market cap
- 256K+
- 52-week range
- $0.217 – $207.00
- 50-day average
- $2.69
- 200-day average
- $18.40
Recent signals
GCTK news
-
Oct 22, 2026:
Glucotrack, Inc. Announces Reverse Stock Split
-
Oct 14, 2026:
Qare™ Is Here: Lōkahi Therapeutics™ Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
-
Oct 14, 2026:
Qare Is Here: Lokahi Therapeutics Launches a Proprietary New Way to Compare Your Care, Beginning with GLP-1 Medications
-
Oct 1, 2026:
Lkahi Therapeutics Expands University of Georgia Collaboration Through First International ai Pipeline Project with Universitt Paderborn
-
Oct 1, 2026:
Lokahi Therapeutics Expands University of Georgia Collaboration Through First International ai² Pipeline Project with Universitat Paderborn
-
Oct 1, 2026:
Lōkahi Therapeutics™ Expands University of Georgia Collaboration Through First International ai² Pipeline™ Project with Universität Paderborn
-
Sep 30, 2026:
Lōkahi Therapeutics™ Announces Qare™, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
-
Sep 30, 2026:
Lokahi Therapeutics Announces Qare, the First Real-Time Comparative Health Platform for GLP-1 Medications, with Public Availability Beginning October 14
About GlucoTrack, Inc.
GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It also focuses on developing a wireless module for transmission of measurement data captured by the GlucoTrack model DF-F to a cloud-based server.
Similar stocks
Find more stocks like GCTK with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.